ReproCELL Incorporated (TYO:4978)
Japan flag Japan · Delayed Price · Currency is JPY
148.00
-1.00 (-0.67%)
Aug 27, 2026, 11:25 AM JST

ReproCELL Revenue

ReproCELL had revenue of 546.00M JPY in the quarter ending June 30, 2026, with 14.95% growth. This brings the company's revenue in the last twelve months to 2.30B, down -18.70% year-over-year. In the fiscal year ending March 31, 2026, ReproCELL had annual revenue of 2.23B, down -25.02%.

Revenue (ttm)
2.30B
Revenue Growth
-18.70%
P/S Ratio
6.34
Revenue / Employee
22.81M
Employees
101
Market Cap
14.60B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20262.23B-745.00M-25.02%
Mar 31, 20252.98B552.00M22.75%
Mar 31, 20242.43B-527.00M-17.85%
Mar 31, 20232.95B719.00M32.18%
Mar 31, 20222.23B948.00M73.72%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
RaQualia Pharma3.90B
Immuno-Biological Laboratories1.08B
AnGes962.00M
SUSMED,Inc.497.00M
Stella Pharma323.00M
Nano Holdings202.00M
CellSeed161.00M
Renascience68.00M
Revenue Rankings

ReproCELL News

More News